Axel J Schmidt1, Adam Bourne2, Peter Weatherburn2, David Reid2, Ulrich Marcus3, Ford Hickson2. 1. Sigma Research, London School of Hygiene and Tropical Medicine, United Kingdom; Swiss Federal Office of Public Health, Bern, Switzerland. Electronic address: axel.j.schmidt@emis-project.eu. 2. Sigma Research, London School of Hygiene and Tropical Medicine, United Kingdom. 3. Robert Koch Institute, Berlin, Germany.
Abstract
BACKGROUND: Anecdotal evidence suggests that men who have sex with men (MSM) are increasingly combining sex and illicit drugs (an activity referred to as 'chemsex'), in particular GHB/GBL, ketamine, crystal meth, or mephedrone (here called 4-chems). Use of such drugs has been associated with mental health and sexual health harms. We aim to compare patterns of illicit drug use among MSM in 44 European urban centres. METHODS: In 2010, EMIS recruited 174,209 men from 38 countries to an anonymous online questionnaire in 25 languages. As harm reduction services for drugs and sex are organised at a local level, we chose to compare cities rather than countries. We defined 44 cities based on region/postal code and settlement size. For multivariable regression analyses, three comparison groups of MSM not living in these cities were applied: MSM living in Germany, the UK, and elsewhere in Europe. RESULTS: Data from 55,446 MSM living in 44 urban centres were included. Use of 4-chems (past 4 weeks) was highest in Brighton (16.3%), Manchester (15.5%), London (13.2%), Amsterdam (11.2%), Barcelona (7.9%), Zurich (7.0%) and Berlin (5.3%). It was lowest in Sofia (0.4%). The rank order was largely consistent when controlling for age, HIV diagnosis, and number of sexual partners. City of residence was the strongest demographic predictor of chemsex-drug use. CONCLUSION: Use of drugs associated with chemsex among MSM varies substantially across European cities. As city is the strongest predictor of chemsex-drug use, effective harm reduction programmes must include structural as well as individual interventions.
BACKGROUND: Anecdotal evidence suggests that men who have sex with men (MSM) are increasingly combining sex and illicit drugs (an activity referred to as 'chemsex'), in particular GHB/GBL, ketamine, crystal meth, or mephedrone (here called 4-chems). Use of such drugs has been associated with mental health and sexual health harms. We aim to compare patterns of illicit drug use among MSM in 44 European urban centres. METHODS: In 2010, EMIS recruited 174,209 men from 38 countries to an anonymous online questionnaire in 25 languages. As harm reduction services for drugs and sex are organised at a local level, we chose to compare cities rather than countries. We defined 44 cities based on region/postal code and settlement size. For multivariable regression analyses, three comparison groups of MSM not living in these cities were applied: MSM living in Germany, the UK, and elsewhere in Europe. RESULTS: Data from 55,446 MSM living in 44 urban centres were included. Use of 4-chems (past 4 weeks) was highest in Brighton (16.3%), Manchester (15.5%), London (13.2%), Amsterdam (11.2%), Barcelona (7.9%), Zurich (7.0%) and Berlin (5.3%). It was lowest in Sofia (0.4%). The rank order was largely consistent when controlling for age, HIV diagnosis, and number of sexual partners. City of residence was the strongest demographic predictor of chemsex-drug use. CONCLUSION: Use of drugs associated with chemsex among MSM varies substantially across European cities. As city is the strongest predictor of chemsex-drug use, effective harm reduction programmes must include structural as well as individual interventions.
Authors: Keith J Horvath; Sara Lammert; Sara LeGrand; Kathryn E Muessig; José A Bauermeister Journal: Curr Opin HIV AIDS Date: 2017-09 Impact factor: 4.283
Authors: H Rhodes Hambrick; Su Hyun Park; Joseph J Palamar; Anthony Estreet; John A Schneider; Dustin T Duncan Journal: Sex Health Date: 2018-07 Impact factor: 2.706
Authors: Blake W Hawkins; Heather L Armstrong; Sarah Kesselring; Ashleigh J Rich; Zishan Cui; Paul Sereda; Terry Howard; Jamie I Forrest; David M Moore; Nathan J Lachowsky; Robert S Hogg; Eric A Roth Journal: Subst Use Misuse Date: 2019-05-29 Impact factor: 2.164
Authors: Natasha K Martin; Klaus Jansen; Matthias An der Heiden; Christoph Boesecke; Anders Boyd; Knud Schewe; Axel Baumgarten; Thomas Lutz; Stefan Christensen; Alexander Thielen; Stefan Mauss; Jürgen K Rockstroh; Britt Skaathun; Patrick Ingiliz Journal: J Infect Dis Date: 2019-10-08 Impact factor: 5.226
Authors: Roman Shrestha; Sin How Lim; Frederick L Altice; Michael Copenhaver; Jeffrey A Wickersham; Rumana Saifi; Mohd Akbar Ab Halim; Herlianna Naning; Adeeba Kamarulzaman Journal: J Community Health Date: 2020-02